SuperworthTyra Biosciences market cap TYRA
Share price times shares outstanding: what the whole company sells for, since 2021.
- Today, Oct 23, 2026
- $1.2B
- Highest close in our data
- $2.2B
- May 2026
Tyra Biosciences is worth $1.2B at the close on Oct 23, 2026, at $20.45 a share.
That is up 61% over the last year and up 4% over five years.
Its highest close in our data was $2.2B in May 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $1.2B | $1.1B | $2.2B | −12% |
| 2025 | $1.4B | $410.9M | $1.4B | +95% |
| 2024 | $712M | $499.9M | $1.4B | +19% |
| 2023 | $596.4M | $289.1M | $745.3M | +86% |
| 2022 | $320.7M | $219.7M | $551.7M | −45% |
| 2021 | $580.6M | $516.2M | $1.2B | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Tyra Biosciences' size, closest first, today.
| Company | Market cap |
|---|---|
| TYRATyra Biosciences | $1.2B |
| OMEROmeros | $1.2B |
| AMPHAmphastar Pharmaceuticals | $1.1B |
| PCRXPacira BioSciences | $1.5B |
| ANABAnaptysbio | $1.5B |
| PAHCPhibro Animal Health | $1.6B |
| ANIPANI Pharmaceuticals | $1.7B |
| ABUSArbutus Biopharma | $831M |
| COLLCollegium Pharmaceutical | $747.5M |
| HRMYHarmony Biosciences | $2.1B |
| PBHPrestige Consumer Healthcare | $2.3B |
| Peer median | $1.5B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Tyra Biosciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.